Physician profile
Brad Johnson
NPI 1013250737
$3,490.66
in general payments reported to CMS, 2019-2025
9 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,559 · 2022: $13.39 · 2023: $362 · 2024: $39.62 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707 · Travel and Lodging: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.99 |
| Travel and Lodging | $211.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,500.00 | 2020 | |
| Boston Scientific Corporation | $422.58 | 2020-2025 | Intracept |
| Medtronic, INC. | $160.19 | 2025 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $124.12 | 2025 | Sprint Pns System |
| Si-Bone, INC. | $117.01 | 2025 | |
| Vertos Medical, INC. | $82.86 | 2023 | Mild Device Kit |
| Abbott Laboratories | $39.62 | 2024 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $30.89 | 2025 | Iovera |
| Coherus Oncology, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.